Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

HHS, RFK sued by medical associations over COVID policy shift
Multiple professional groups, including the American Academy of Pediatrics and the American College of Physicians, challenge recent policy changes to vaccine recommendations for COVID-19, which end routine inoculations for minors and pregnant women.
New TAVR valve from MiRus linked to positive early outcomes
The Siegel TAVR valve includes no nickel or cobalt. In fact, its frame was built using special alloys specifically developed by MiRus.
EHR-driven PCI risk assessments could make a world of difference
Researchers with Mayo Clinic have shown that EHR-driven risk assessments could go a long way toward improving care for PCI patients.
FDA expands approval of Boston Scientific’s Farapulse PFA system
The FDA's 2024 approval of the Farapulse system covered patients with paroxysmal atrial fibrillation. Now, however, the technology is officially approved for patients with more persistent symptoms.
No biopsy required: Blood test could spot signs of rejection in heart transplant recipients
It may not always be necessary to subject heart transplant patients to one biopsy after another.

When STEMI patients present late, immediate and delayed PCI lead to similar outcomes

Exploring data from nearly 6,000 STEMI patients, the study's authors aimed to learn more about the impact of immediate vs. delayed PCI.

Apixaban appears safe for most TAVR patients, but questions remain

Researchers tracked data from more than 1,500 patients who underwent a successful TAVR procedure from 2016 to 2019.

Elective revascularization with PCI or CABG provides long-term cardiovascular benefits, new meta-analysis confirms

Researchers evaluated data from 25 different randomized clinical trials, sharing their findings virtually at EuroPCR 2021.

Dapagliflozin fails to reduce the risk of organ failure or death among COVID-19 patients

Patients given the SGLT2 inhibitor did experience improved outcomes, the researchers noted, but none of the differences were statistically significant.

A milestone for Medtronic: Low-risk TAVR patients treated with Evolut ‘doing exceptionally well’ after 2 years

The two-year rates of all-cause mortality or disabling stroke were 4.3% for TAVR patients and 6.3% for SAVR patients.

Abbott’s new self-expanding TAVR system gains CE mark approval

The solution has still only been approved in the United States for investigational use.

Finerenone limits AFib in patients with chronic kidney disease, Type 2 diabetes

This secondary analysis of data from the FIDELIO-DKD trial was presented May 17 at ACC.21 and published in the Journal of the American College of Cardiology.

Alcohol—even just one drink—increases the risk of AFib

The study's authors believe they are the first group to investigate the real-time relationship between alcohol consumption and AFib events.

Clinical

HHS, RFK sued by medical associations over COVID policy shift

New TAVR valve from MiRus linked to positive early outcomes

EHR-driven PCI risk assessments could make a world of difference

FDA expands approval of Boston Scientific’s Farapulse PFA system

No biopsy required: Blood test could spot signs of rejection in heart transplant recipients